Treatment of chronic hepatitis C with PEGylated interferon and ribavirin.

被引：69
|
作者：
Cornberg M. [1 ]
Wedemeyer H. [1 ]
Manns M.P. [1 ]
机构：
[1] Department of Gastroenterology, Hepatology, and Endocrinology, Medical School Hannover, Carl-Neuberg-Strasse 1
来源：
Current Gastroenterology Reports | 2002年 / 4卷 / 1期
关键词：
Sustained Virologic Response; Sustained Virologic Response Rate; Million Unit; Sustained Response Rate; International Hepatitis Interventional Therapy Group;
D O I：
10.1007/s11894-002-0034-y
中图分类号：
学科分类号：
摘要：
Treatment with interferon alfa combined with ribavirin is successful in approximately 40% to 45% of patients with chronic hepatitis C viral infection (HCV). However, response rates are disappointing in patients who are difficult to treat, such as those infected with HCV genotype 1, high viral load, or advanced liver fibrosis. In addition, low tolerability and significant side effects of therapy frequently lead to dose reduction and treatment discontinuation, decreasing response rates further. Thus, investigation of new treatment options and innovations for chronic HCV infection are vital. This review describes recent advances in the treatment of HCV infection with PEGylated interferon (interferon modified with polyethylene glycol [PEG] ) combined with ribavirin.
引用
收藏
页码：23 / 30
页数：7
相关论文
共 50 条
  • [1] Hepatitis C core antigen response to treatment with pegylated interferon and ribavirin.
    Zacks, S
    Peace-Brewer, A
    Orton, S
    Theodore, D
    Pusek, S
    Shrestha, R
    Fried, MW
    [J]. HEPATOLOGY, 2002, 36 (04) : 356A - 356A
  • [2] Pegylated Interferon and Ribavirin for the Treatment of Chronic Hepatitis C
    Kemp, William
    Roberts, Stuart
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 137 - 150
  • [3] Treatment of patients with recurrent hepatitis C after liver transplantation with pegylated interferon and ribavirin.
    Samuel, D
    [J]. HEPATOLOGY, 2003, 38 (04) : 531A - 531A
  • [4] Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
    Carvalho-Filho, Roberto J.
    Dalgard, Olav
    [J]. PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2010, 3 : 1 - 13
  • [5] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    [J]. Current Gastroenterology Reports, 2006, 8 (1) : 46 - 52
  • [6] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    [J]. Current Hepatitis Reports, 2006, 5 (3) : 114 - 120
  • [7] Treatment of chronic hepatitis C with interferon alpha and ribavirin. Results in "real life"
    Pariente, A
    Djilloul, A
    Cadranel, JF
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2003, 27 (6-7): : 590 - 595
  • [8] Hepatitis C and treatment with pegylated interferon and ribavirin
    Gotto, J
    Dusheiko, GM
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (10): : 1874 - 1877
  • [9] Retinopathy associated with pegylated interferon and ribavirin treatment for chronic hepatitis C
    Adams, Shelly
    Ostermeier, Mark
    [J]. OPTOMETRY-JOURNAL OF THE AMERICAN OPTOMETRIC ASSOCIATION, 2010, 81 (11) : 580 - 586
  • [10] Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin
    Onyike, CU
    Bonner, JO
    Lyketsos, CG
    Treisman, GJ
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (03): : 429 - 435
12345